About 2seventy bio
2seventy bio is a company based in Cambridge (United States) founded in 2021 was acquired by Bristol-Myers Squibb in March 2025.. The company has 416 employees as of December 31, 2021. 2seventy bio offers products and services including Gene and Cell Therapies. 2seventy bio operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cambridge, United States
- Employees 416 as on 31 Dec, 2021
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name 2Seventy Bio, Inc.
-
Annual Revenue
$37.86 M-62as on Dec 31, 2024
-
Net Profit
$-57.25 M74as on Dec 31, 2024
-
EBITDA
$-115.43 M51as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
416
as on Dec 31, 2021
-
Acquired by
Bristol-Myers Squibb
(Mar 11, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of 2seventy bio
2seventy bio offers a comprehensive portfolio of products and services, including Gene and Cell Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops therapies to target and treat cancer for improved patient outcomes
Unlock access to complete
Unlock access to complete
Funding Insights of 2seventy bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in 2seventy bio
2seventy bio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bristol-Myers Squibb. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacturer of drugs for oncology, HIV/AIDS, cardiovascular disease, rheumatoid arthritis, and hepatitis
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by 2seventy bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - 2seventy bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
2Seventy Bio Comparisons
Competitors of 2seventy bio
2seventy bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about 2seventy bio
When was 2seventy bio founded?
2seventy bio was founded in 2021.
Where is 2seventy bio located?
2seventy bio is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Who is the current CEO of 2seventy bio?
Nick Leschly is the current CEO of 2seventy bio.
How many employees does 2seventy bio have?
As of Dec 31, 2021, the latest employee count at 2seventy bio is 416.
What is the annual revenue of 2seventy bio?
Annual revenue of 2seventy bio is $37.86M as on Dec 31, 2024.
What does 2seventy bio do?
The company was founded in 2021 and is headquartered in Cambridge, United States. Cellular therapies targeting cancer are developed, with a focus on hematologic malignancies. Engineered approaches combining lentiviral vectors, CAR-T, and TCR technologies are utilized to control and eliminate tumors. The flagship product, Abecma, is approved for multiple myeloma, while additional therapies are advanced for broader applications in this sector.
Who are the top competitors of 2seventy bio?
2seventy bio's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does 2seventy bio offer?
2seventy bio offers Gene and Cell Therapies.
Who are 2seventy bio's investors?
2seventy bio has 1 investor. Key investors include Bristol-Myers Squibb.